These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5883399)

  • 21. Kinetics of water-soluble contrast media in the central nervous system.
    Sage MR
    AJR Am J Roentgenol; 1983 Oct; 141(4):815-24. PubMed ID: 6351570
    [No Abstract]   [Full Text] [Related]  

  • 22. [Homeostasis in the central nervous system].
    Leusen I
    Verh K Acad Geneeskd Belg; 1982; 44(1):5-26. PubMed ID: 7136246
    [No Abstract]   [Full Text] [Related]  

  • 23. 'Blood-brain barrier' concept and the kinetics of 22Na escape from the central nervous system of Periplaneta americana.
    Pichon Y; Tucker LE
    J Physiol; 1971 Dec; 219(2):24P-25P. PubMed ID: 5158381
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative characteristics of the changes in the protein makeup and immunobiological properties of the cerebrospinal fluid and blood serum in experimental trypanosomiasis in rabbits].
    Kuzovkov AG; Nikitin AF; Badikov VD
    Parazitologiia; 1980; 14(2):149-57. PubMed ID: 7375137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A property of cerebrospinal fluid indicating disturbed metabolism within the central nervous system.
    CHAPMAN LF; WOLFF HG
    Trans Assoc Am Physicians; 1958; 71():210-24. PubMed ID: 13603518
    [No Abstract]   [Full Text] [Related]  

  • 28. [Blood-brain and blood-cerebrospinal fluid barriers under physiological conditions and in inflammatory states of the central nervous system].
    Majchrowicz H
    Przegl Epidemiol; 1983; 37(3-4):403-7. PubMed ID: 6665198
    [No Abstract]   [Full Text] [Related]  

  • 29. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
    Strazielle N; Khuth ST; Ghersi-Egea JF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
    Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
    Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of ionizing radiation on central nervous system].
    Romodanov AP; Baraboĭ VA; Sutkovoĭ DA
    Fiziol Zh (1994); 1994; 40(2):107-21. PubMed ID: 7758597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a high-throughput brain slice method for studying drug distribution in the central nervous system.
    Fridén M; Ducrozet F; Middleton B; Antonsson M; Bredberg U; Hammarlund-Udenaes M
    Drug Metab Dispos; 2009 Jun; 37(6):1226-33. PubMed ID: 19299522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The blood-brain barrier. II. Physiological data (conclusion)].
    Lefauconnier JM; Hauw JJ
    Rev Neurol (Paris); 1984; 140(2):89-109. PubMed ID: 6143382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide and peptide analog transport systems at the blood-CSF barrier.
    Smith DE; Johanson CE; Keep RF
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1765-91. PubMed ID: 15381333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics].
    Turkulov V; Madle-Samardzija N; Ilić A; Vukadinov J; Canak G
    Med Pregl; 1998; 51(9-10):436-40. PubMed ID: 9863335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Function of purification drainage of the central nervous system through the cerebrospinal fluid].
    dos Reis-Filho JB
    Arq Neuropsiquiatr; 1983 Mar; 41(1):80-5. PubMed ID: 6870589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mineral metabolism of the central nervous system; preliminary report].
    EICHHORN O
    Wien Z Nervenheilkd Grenzgeb; 1954; 9(1-2):165-70. PubMed ID: 13188010
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategies to optimize brain penetration in drug discovery.
    Liu X; Chen C
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):505-12. PubMed ID: 16022187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery across the blood-brain barrier.
    Gaillard PJ; Visser CC; de Boer AG
    Expert Opin Drug Deliv; 2005 Mar; 2(2):299-309. PubMed ID: 16296755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.